{
    "clinical_study": {
        "@rank": "30045", 
        "arm_group": [
            {
                "arm_group_label": "amlodipine camsylate", 
                "arm_group_type": "Experimental", 
                "description": "amlodipine camsylate 5mg"
            }, 
            {
                "arm_group_label": "losartan potassium", 
                "arm_group_type": "Active Comparator", 
                "description": "losartan potassium 50mg"
            }
        ], 
        "brief_summary": {
            "textblock": "This study was conducted to evaluate and compare the effectiveness of Amodipin\u00ae (amlodipine\n      camsylate) with that of Cozaar\u00ae (losartan potassium) in hypertensive patients with an acute\n      ischemic stroke by measuring their 24-hour ambulatory BP (ABP)."
        }, 
        "brief_title": "Diurnal Variation in Hypertensive Stroke Patients", 
        "completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Hypertension", 
            "Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Stroke", 
                "Cerebral Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. aged 35 to 85 years\n\n          2. hypertensive patients who had an ischemic stroke\n\n        Exclusion Criteria:\n\n          1. patients aged below 35 years or above 86 years;\n\n          2. patients who had a hemorrhagic stroke;\n\n          3. patients whose systolic BP (SBP) was over 220 mmHg or whose diastolic BP (DBP) was\n             above 120 mmHg during an acute phase, or whose SBP was over 180 mmHg or whose DBP was\n             over 110 mmHg one week after their hospital visit;\n\n          4. patients with secondary hypertension related to renovascular, endocrinologic, or\n             pregnant conditions\n\n          5. patients who went to bed in the middle of the day or very late at night; (6) patients\n             who were using intravenous antico-agulants or thrombolytics;\n\n        (7) patients with a severe stroke (NIH stroke scale > 20); (8) patients who could not give\n        their consent to investigators; (9) patients with severely impaired liver function (AST or\n        ALT \u2265 100); (10) patients with severely impaired renal function (serum creatinine  \u2265 2.0\n        mg/dL); (11) patients with cancer; (12) patients who were pregnant or lactating; (13)\n        patients with other grave diseases such as hypertensive encephalopathy, aortic dissection,\n        acute myocardial infarction, or severe congestive heart failure; and (14) patients who\n        were allergic to the test or control drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "84", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830517", 
            "org_study_id": "HM-AMO-401"
        }, 
        "intervention": {
            "arm_group_label": [
                "amlodipine camsylate", 
                "losartan potassium"
            ], 
            "intervention_name": "Amlodipine, Losartan", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Amlodipine", 
                "Losartan"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 11, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boramae-ro 5-gil 20, Dongjak-gu", 
                    "country": "Korea, Republic of", 
                    "state": "Seoul", 
                    "zip": "156-707"
                }, 
                "name": "Boramae Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of the Effects of Amlodipine and Losartan on Blood Pressure and Diurnal Variation in Hypertensive Stroke Patients", 
        "overall_official": {
            "affiliation": "SMG-SNU Boramae Medical Center", 
            "last_name": "Hyunwoo Nam, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "24-hour ambulatory mean SBP", 
            "safety_issue": "No", 
            "time_frame": "baseline and 8weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830517"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "24H mean DBP, 24H mean SBP/DBP Variability,clinic SBP/DBP, awake, sleep, morning, evening, and prewake BPs, the morning surge, and the nocturnal dipping", 
            "safety_issue": "No", 
            "time_frame": "baseline and 8weeks"
        }, 
        "source": "Hanmi Pharmaceutical Company Limited", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hanmi Pharmaceutical Company Limited", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2007", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}